|
|
News Breaks
|
November 10, 2009
|
| 08:35 EDT |  | AVNR |
| theflyonthewall.com: | Avanir Pharmaceuticals announces Zenvia safety and efficacy data | | AVANIR Pharmaceuticals announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia in the treatment of patients with pseudobulbar affect. :theflyonthewall.com |
|
|
News For AVNR From The Last 14 Days Check below for free stories on AVNR the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 8, 2012
|
| 09:12 EDT | | AVNR |
| theflyonthewall.com: | Avanir Pharmaceuticals' AVP-923 for diabetis shows positive Phase III results |
 Subscribe for More Information :theflyonthewall.com |
|
|
February 7, 2012
|
| 16:10 EDT |  | AVNR |
|
|
|
|
|
